US Stock MarketDetailed Quotes

Biorestorative Therapies (BRTX)

Watchlist
  • 0.1860
  • -0.0115-5.82%
Close May 13 16:00 ET
  • 0.1965
  • +0.0105+5.65%
Post 19:50 ET
4.74MMarket Cap-0.12P/E (TTM)

Biorestorative Therapies (BRTX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
-10.30%359.7K
-54.73%19.6K
-94.95%11.8K
240.40%303.3K
-28.57%25K
175.03%401K
124.35%43.3K
660.91%233.6K
38.14%89.1K
11.82%35K
Operating revenue
-10.30%359.7K
-54.73%19.6K
-94.95%11.8K
240.40%303.3K
-28.57%25K
175.03%401K
124.35%43.3K
660.91%233.6K
38.14%89.1K
11.82%35K
Cost of revenue
-15.06%23.84K
-51.00%1.64K
-42.06%10.57K
34.50%8.73K
2.91K
28.07K
3.34K
18.24K
6.49K
0
Gross profit
-9.94%335.86K
-55.05%17.96K
-99.43%1.23K
256.58%294.57K
-36.88%22.09K
155.78%372.93K
107.05%39.96K
601.49%215.36K
28.08%82.61K
35K
Operating expense
33.99%15.98M
40.77%3.84M
48.27%3.71M
41.09%3.6M
16.54%4.83M
-21.95%11.93M
-15.74%2.73M
-18.00%2.5M
-19.79%2.55M
-28.68%4.14M
Selling and administrative expenses
12.78%5.89M
18.30%1.22M
6.34%1.12M
25.20%1.37M
0.95%3.12M
-53.93%5.22M
-52.18%1.03M
-54.89%1.05M
-51.83%1.1M
-32.60%3.09M
-General and administrative expense
12.78%5.89M
18.30%1.22M
6.34%1.12M
25.20%1.37M
0.95%3.12M
-53.93%5.22M
-52.18%1.03M
-54.89%1.05M
-51.83%1.1M
-32.60%3.09M
Research and development costs
50.51%10.09M
54.35%2.63M
78.53%2.59M
53.09%2.23M
62.01%1.71M
66.24%6.71M
56.14%1.7M
79.47%1.45M
61.04%1.45M
-14.09%1.06M
Operating profit
-35.41%-15.65M
-42.20%-3.83M
-62.18%-3.71M
-33.88%-3.31M
-16.99%-4.81M
23.66%-11.56M
16.47%-2.69M
24.30%-2.29M
20.78%-2.47M
28.89%-4.11M
Net non-operating interest income expense
-56.79%266.21K
-70.93%34.59K
-63.58%57.74K
-57.99%73.92K
-38.52%99.97K
11.55%616.08K
-68.37%118.99K
157.10%158.55K
82.92%175.95K
792.61%162.6K
Non-operating interest income
-56.79%266.21K
-70.93%34.59K
-63.58%57.74K
-57.99%73.92K
-38.52%99.97K
11.55%616.08K
-68.37%118.99K
157.10%158.55K
82.92%175.95K
792.61%162.6K
Other net income (expense)
-41.88%1.14M
-37.64%583.08K
-40.89%612.99K
133.13%575.11K
-136.69%-632.23K
-52.98%1.96M
73.00%935.01K
-86.58%1.04M
35.45%-1.74M
222.08%1.72M
Gain on sale of security
-38.00%1.12M
-39.13%568.97K
-40.95%612.06K
133.09%574.59K
-140.28%-634.12K
-54.75%1.81M
79.32%934.65K
-86.53%1.04M
36.36%-1.74M
205.78%1.57M
Other non- operating income (expenses)
-88.43%17.45K
3,909.09%14.11K
64.31%930
-43.14%518
-98.73%1.89K
-11.09%150.85K
-98.17%352
-98.33%566
-97.71%911
94.39%149.02K
Income before tax
-58.61%-14.24M
-96.05%-3.21M
-178.38%-3.04M
34.06%-2.66M
-140.18%-5.34M
13.81%-8.98M
28.99%-1.64M
-122.89%-1.09M
29.44%-4.03M
69.00%-2.22M
Income tax
Net income
-58.61%-14.24M
-96.05%-3.21M
-178.38%-3.04M
34.06%-2.66M
-140.18%-5.34M
13.81%-8.98M
28.99%-1.64M
-122.89%-1.09M
29.44%-4.03M
69.00%-2.22M
Net income continuous Operations
-58.61%-14.24M
-96.05%-3.21M
-178.38%-3.04M
34.06%-2.66M
-140.18%-5.34M
13.81%-8.98M
28.99%-1.64M
-122.89%-1.09M
29.44%-4.03M
69.00%-2.22M
Minority interest income
Net income attributable to the parent company
-58.61%-14.24M
-96.05%-3.21M
-178.38%-3.04M
34.06%-2.66M
-140.18%-5.34M
13.81%-8.98M
28.99%-1.64M
-122.89%-1.09M
29.44%-4.03M
69.00%-2.22M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-58.61%-14.24M
-96.05%-3.21M
-178.38%-3.04M
34.06%-2.66M
-140.18%-5.34M
13.81%-8.98M
28.99%-1.64M
-122.89%-1.09M
29.44%-4.03M
69.00%-2.22M
Basic earnings per share
-36.21%-1.58
-60.00%-0.32
-153.85%-0.33
40.00%-0.3
-93.94%-0.64
53.04%-1.16
57.45%-0.2
-112.50%-0.13
65.99%-0.5
82.90%-0.33
Diluted earnings per share
-36.21%-1.58
-60.00%-0.32
-153.85%-0.33
40.00%-0.3
-93.94%-0.64
53.04%-1.16
57.45%-0.2
-133.33%-0.13
65.99%-0.5
82.90%-0.33
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue -10.30%359.7K-54.73%19.6K-94.95%11.8K240.40%303.3K-28.57%25K175.03%401K124.35%43.3K660.91%233.6K38.14%89.1K11.82%35K
Operating revenue -10.30%359.7K-54.73%19.6K-94.95%11.8K240.40%303.3K-28.57%25K175.03%401K124.35%43.3K660.91%233.6K38.14%89.1K11.82%35K
Cost of revenue -15.06%23.84K-51.00%1.64K-42.06%10.57K34.50%8.73K2.91K28.07K3.34K18.24K6.49K0
Gross profit -9.94%335.86K-55.05%17.96K-99.43%1.23K256.58%294.57K-36.88%22.09K155.78%372.93K107.05%39.96K601.49%215.36K28.08%82.61K35K
Operating expense 33.99%15.98M40.77%3.84M48.27%3.71M41.09%3.6M16.54%4.83M-21.95%11.93M-15.74%2.73M-18.00%2.5M-19.79%2.55M-28.68%4.14M
Selling and administrative expenses 12.78%5.89M18.30%1.22M6.34%1.12M25.20%1.37M0.95%3.12M-53.93%5.22M-52.18%1.03M-54.89%1.05M-51.83%1.1M-32.60%3.09M
-General and administrative expense 12.78%5.89M18.30%1.22M6.34%1.12M25.20%1.37M0.95%3.12M-53.93%5.22M-52.18%1.03M-54.89%1.05M-51.83%1.1M-32.60%3.09M
Research and development costs 50.51%10.09M54.35%2.63M78.53%2.59M53.09%2.23M62.01%1.71M66.24%6.71M56.14%1.7M79.47%1.45M61.04%1.45M-14.09%1.06M
Operating profit -35.41%-15.65M-42.20%-3.83M-62.18%-3.71M-33.88%-3.31M-16.99%-4.81M23.66%-11.56M16.47%-2.69M24.30%-2.29M20.78%-2.47M28.89%-4.11M
Net non-operating interest income expense -56.79%266.21K-70.93%34.59K-63.58%57.74K-57.99%73.92K-38.52%99.97K11.55%616.08K-68.37%118.99K157.10%158.55K82.92%175.95K792.61%162.6K
Non-operating interest income -56.79%266.21K-70.93%34.59K-63.58%57.74K-57.99%73.92K-38.52%99.97K11.55%616.08K-68.37%118.99K157.10%158.55K82.92%175.95K792.61%162.6K
Other net income (expense) -41.88%1.14M-37.64%583.08K-40.89%612.99K133.13%575.11K-136.69%-632.23K-52.98%1.96M73.00%935.01K-86.58%1.04M35.45%-1.74M222.08%1.72M
Gain on sale of security -38.00%1.12M-39.13%568.97K-40.95%612.06K133.09%574.59K-140.28%-634.12K-54.75%1.81M79.32%934.65K-86.53%1.04M36.36%-1.74M205.78%1.57M
Other non- operating income (expenses) -88.43%17.45K3,909.09%14.11K64.31%930-43.14%518-98.73%1.89K-11.09%150.85K-98.17%352-98.33%566-97.71%91194.39%149.02K
Income before tax -58.61%-14.24M-96.05%-3.21M-178.38%-3.04M34.06%-2.66M-140.18%-5.34M13.81%-8.98M28.99%-1.64M-122.89%-1.09M29.44%-4.03M69.00%-2.22M
Income tax
Net income -58.61%-14.24M-96.05%-3.21M-178.38%-3.04M34.06%-2.66M-140.18%-5.34M13.81%-8.98M28.99%-1.64M-122.89%-1.09M29.44%-4.03M69.00%-2.22M
Net income continuous Operations -58.61%-14.24M-96.05%-3.21M-178.38%-3.04M34.06%-2.66M-140.18%-5.34M13.81%-8.98M28.99%-1.64M-122.89%-1.09M29.44%-4.03M69.00%-2.22M
Minority interest income
Net income attributable to the parent company -58.61%-14.24M-96.05%-3.21M-178.38%-3.04M34.06%-2.66M-140.18%-5.34M13.81%-8.98M28.99%-1.64M-122.89%-1.09M29.44%-4.03M69.00%-2.22M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -58.61%-14.24M-96.05%-3.21M-178.38%-3.04M34.06%-2.66M-140.18%-5.34M13.81%-8.98M28.99%-1.64M-122.89%-1.09M29.44%-4.03M69.00%-2.22M
Basic earnings per share -36.21%-1.58-60.00%-0.32-153.85%-0.3340.00%-0.3-93.94%-0.6453.04%-1.1657.45%-0.2-112.50%-0.1365.99%-0.582.90%-0.33
Diluted earnings per share -36.21%-1.58-60.00%-0.32-153.85%-0.3340.00%-0.3-93.94%-0.6453.04%-1.1657.45%-0.2-133.33%-0.1365.99%-0.582.90%-0.33
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More